MAP3K

MAP3K(丝裂原活化蛋白激酶激酶)是 MAPK 级联的顶级成分,通过独特的蛋白质-蛋白质相互作用和信号效应分子的磷酸化,特异性地激活依赖刺激的 MAP2K-MAPK 通路。MAP3K 的基因数量和结构差异很大,包括 TAK1、ASK1、A-Raf 和 C-Raf。

MAPK 系统是一个三步连续的磷酸化级联,由 MAPK、MAP2K 和 MAP3K 组成。ERK、p38 MAPK 和 JNK 属于 MAPK 家族,已知它们受机械刺激激活。MAP3K 的作用是“整合 MAPK 信号传导的平台,多种 MAP3K 的激活提供了 MAPK 通路的时空调控,从而诱导了决定细胞命运所需的多种生理反应,例如细胞因子的产生、存活、分化和凋亡”。

MAP3Ks (Mitogen-activated protein kinase kinase kinases), the top components of MAPK cascades, provide specificity for stimulus-dependent activation of MAP2K-MAPK pathways through unique protein-protein interactions and phosphorylation of signaling effectors. The MAP3Ks are highly divergent in gene numbers and structure, including TAK1, ASK1, A-Raf and C-Raf.

MAPK system is a three-step sequential phosphorylation cascade which is composed of MAPK, MAP2K, and MAP3K. ERK, p38 MAPK, and JNK, which are known to be activated by mechanical stimuli, belong to the MAPK family. MAP3Ks function as “platforms to integrate MAPK signaling, and activation of multiple MAP3Ks provides the spatiotemporal regulation of the MAPK pathways, which induces a wide range of physiological responses required for determining cell fate, such as cytokine production, survival, differentiation and apoptosis”.

共 1种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
PROTAC LZK degrader 1

PROTAC LZK degrader 1 (Compound 21A) 是一种靶向降解 LZK(亮氨酸拉链激酶,由 MAP3K13 编码)的 PROTAC,其在 10 μM 浓度下可促进 LZK 降解并抑制 p53 和 c-MYC 的表达,从而导致全球头颈部鳞状细胞癌 (HNSCC) 细胞系的活力受损,可用于抗癌领域研究(粉色:MAP3K13/LZK 配体;蓝色:VHL 配体 (MS-R95960);黑色:连接子 (MS-O13775))。

2763268-64-8
Degrader
PROTAC LZK degrader 1

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础